Investor Presentation March 2023 slide image

Investor Presentation March 2023

Inotiv's Competitive Positioning-Filling a Gap Annual Revenue Service Orientation Client Base Profile Small Independent Service Providers <$20 MM per entity One-off preclinical services Emerging biopharma and specialty support of large pharma Competitive Differentiation Customer service Market Characteristics Fragmented inōtiv analyze, answer. advance. $547.7 MM1 Comprehensive preclinical services, research models, and some clinical services Emerging biopharma, small and medium pharma, Universities, other CRO's Government We Want to provide "White glove" customer service; agility; comprehensive offering from discovery through pre-clinical; consultative Unique in North America and Western Europe; no other provider with same breadth of services and fewer than 10,000 people; agile and responsive Large CROS $ in billions Primarily clinical services; some preclinical services Primarily large pharma Breadth of services; cost plus; room rate per hour Consolidated at the top: Charles River, Covance, ICON, IQVIA, Medpace, PPD 1 FY 2022 revenue. 19
View entire presentation